Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis
| dc.contributor.author | Wang, Yanwen | |
| dc.contributor.author | Zidichouski, Jeffrey A. | |
| dc.date.accessioned | 2018-09-27T11:15:38Z | |
| dc.date.available | 2018-09-27T11:15:38Z | |
| dc.date.issued | 2018-07-02 | |
| dc.date.updated | 2018-09-27T11:15:38Z | |
| dc.description.abstract | Elevation of circulating levels of blood cholesterol, especially LDL cholesterol, and/or the decrease of HDL cholesterol levels have long been recognized as primary risk factors for developing atherosclerosis that leads to cardiovascular and cerebrovascular disease. Hypertriglyceridemia is an independent risk factor that is known to contribute to the development of atherosclerosis. Thus, various interventional efforts aimed at reducing hypercholesterolemia and hypertriglyceridemia have been practiced clinically for decades to reduce morbidity and mortality risk associated with deleterious cardiovascular and cerebrovascular events. As such, many drugs have been developed and clinically used to treat hypocholesteremia and/or hypertriglyceridemia; however, dietary approaches including supplements along with changes in nutrition and lifestyle have become increasingly attractive and acceptable methods used to control borderline or moderately increased levels of blood cholesterol and triacylglycerols. In this regard, the use of a plant/herbal bioactive compound, berberine (BBR), has recently been studied extensively in terms of its efficacy as well as its mechanisms of action and safety as an alternative intervention that beneficially modulates blood lipids. The aim of this review is to provide a comprehensive update on BBR research, new concepts and directions in terms of product development and current challenges, and future prospects of using BBR to manage diseases and complications associated with dyslipidemia. | |
| dc.description.version | Peer Reviewed | |
| dc.identifier.citation | Yanwen Wang and Jeffrey A. Zidichouski, “Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis,” Cholesterol, vol. 2018, Article ID 7173920, 17 pages, 2018. doi:10.1155/2018/7173920 | |
| dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/33012 | |
| dc.identifier.uri | http://dx.doi.org/10.1155/2018/7173920 | |
| dc.identifier.uri | http://hdl.handle.net/1880/108076 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | Copyright © 2018 Yanwen Wang and Jeffrey A. Zidichouski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
| dc.title | Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis | |
| dc.type | Journal Article |